• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于指纹图谱和数据挖掘技术探索作为组蛋白去乙酰化酶9(HDAC9)抑制剂的某些生物活性化合物。

Exploration of Fingerprints and Data Mining-based Prediction of Some Bioactive Compounds from as Histone Deacetylase 9 (HDAC9) Inhibitors.

作者信息

Das Totan, Bhattacharya Arijit, Jha Tarun, Gayen Shovanlal

机构信息

Department of Pharmaceutical Technology, Laboratory of Drug Design and Discovery, Jadavpur University, Kolkata, 700032, India.

Department of Pharmaceutical Technology, Natural Science Laboratory, Division of Medicinal and Pharmaceutical Chemistry, Jadavpur University, Kolkata, 700032, India.

出版信息

Curr Comput Aided Drug Des. 2025;21(3):270-284. doi: 10.2174/0115734099282303240126061624.

DOI:10.2174/0115734099282303240126061624
PMID:38321909
Abstract

BACKGROUND

Histone deacetylase 9 (HDAC9) is an important member of the class IIa family of histone deacetylases. It is well established that over-expression of HDAC9 causes various types of cancers including gastric cancer, breast cancer, ovarian cancer, liver cancer, lung cancer, lymphoblastic leukaemia, etc. The important role of HDAC9 is also recognized in the development of bone, cardiac muscles, and innate immunity. Thus, it will be beneficial to find out the important structural attributes of HDAC9 inhibitors for developing selective HDAC9 inhibitors with higher potency.

METHODS

The classification QSAR-based methods namely Bayesian classification and recursive partitioning method were applied to a dataset consisting of HADC9 inhibitors. The structural features strongly suggested that sulphur-containing compounds can be a good choice for HDAC9 inhibition. For this reason, these models were applied further to screen some natural compounds from Allium sativum. The screened compounds were further accessed for the ADME properties and docked in the homology-modelled structure of HDAC9 in order to find important amino acids for the interaction. The best-docked compound was considered for molecular dynamics (MD) simulation study.

RESULTS

The classification models have identified good and bad fingerprints for HDAC9 inhibition. The screened compounds like ajoene, 1,2 vinyl dithiine, diallyl disulphide and diallyl trisulphide had been identified as compounds having potent HDAC9 inhibitory activity. The results from ADME and molecular docking study of these compounds show the binding interaction inside the active site of the HDAC9. The best-docked compound ajoene shows satisfactory results in terms of different validation parameters of MD simulation study.

CONCLUSION

This modelling study has identified the natural potential lead (s) from . Specifically, the ajoene with the best features can be considered for further and investigation to establish as potential HDAC9 inhibitors.

摘要

背景

组蛋白去乙酰化酶9(HDAC9)是组蛋白去乙酰化酶IIa类家族的重要成员。已明确HDAC9的过表达会导致多种类型的癌症,包括胃癌、乳腺癌、卵巢癌、肝癌、肺癌、淋巴细胞白血病等。HDAC9在骨骼、心肌和先天免疫的发育中也发挥着重要作用。因此,找出HDAC9抑制剂的重要结构特征对于开发更高效的选择性HDAC9抑制剂将是有益的。

方法

基于分类定量构效关系的方法,即贝叶斯分类法和递归划分法,应用于由HADC9抑制剂组成的数据集。结构特征强烈表明含硫化合物可能是抑制HDAC9的良好选择。因此,这些模型被进一步应用于筛选大蒜中的一些天然化合物。对筛选出的化合物进一步评估其药物代谢动力学性质,并将其对接至HDAC9的同源建模结构中,以找出相互作用的重要氨基酸。对对接效果最佳的化合物进行分子动力学(MD)模拟研究。

结果

分类模型已识别出HDAC9抑制的优劣指纹。筛选出的化合物如阿霍烯、1,2-乙烯基二硫醚、二烯丙基二硫化物和二烯丙基三硫化物已被鉴定为具有强大HDAC9抑制活性的化合物。这些化合物的药物代谢动力学和分子对接研究结果显示了它们在HDAC9活性位点内的结合相互作用。对接效果最佳的化合物阿霍烯在MD模拟研究的不同验证参数方面显示出令人满意的结果。

结论

本建模研究已从……中识别出天然潜在先导物。具体而言,具有最佳特征的阿霍烯可考虑进一步进行……和……研究,以确立其作为潜在HDAC9抑制剂的地位。

相似文献

1
Exploration of Fingerprints and Data Mining-based Prediction of Some Bioactive Compounds from as Histone Deacetylase 9 (HDAC9) Inhibitors.基于指纹图谱和数据挖掘技术探索作为组蛋白去乙酰化酶9(HDAC9)抑制剂的某些生物活性化合物。
Curr Comput Aided Drug Des. 2025;21(3):270-284. doi: 10.2174/0115734099282303240126061624.
2
Homology modeling and design of novel and potential dual-acting inhibitors of human histone deacetylases HDAC5 and HDAC9 isozymes.同源建模和新型潜在双重作用人组蛋白去乙酰化酶 HDAC5 和 HDAC9 同工酶抑制剂的设计。
J Biomol Struct Dyn. 2021 Oct;39(17):6396-6414. doi: 10.1080/07391102.2020.1798812. Epub 2020 Jul 27.
3
Histone deacetylase 8 in focus: Decoding structural prerequisites for innovative epigenetic intervention beyond hydroxamates.聚焦组蛋白去乙酰化酶8:解读超越异羟肟酸酯的创新表观遗传干预的结构前提条件。
Int J Biol Macromol. 2025 Jan;284(Pt 2):138119. doi: 10.1016/j.ijbiomac.2024.138119. Epub 2024 Nov 26.
4
Exploring different classification-dependent QSAR modelling strategies for HDAC3 inhibitors in search of meaningful structural contributors.探索基于不同分类的 HDAC3 抑制剂的定量构效关系建模策略,以寻找有意义的结构贡献因素。
SAR QSAR Environ Res. 2024 May;35(5):367-389. doi: 10.1080/1062936X.2024.2350504. Epub 2024 May 17.
5
Diarylcyclopropane hydroxamic acid inhibitors of histone deacetylase 4 designed by combinatorial approach and QM/MM calculations.组合方法和 QM/MM 计算设计的组蛋白去乙酰化酶 4 的二芳基环丙烷羟肟酸抑制剂。
J Mol Graph Model. 2018 Oct;85:97-110. doi: 10.1016/j.jmgm.2018.08.008. Epub 2018 Aug 16.
6
Exploring structural requirements of HDAC10 inhibitors through comparative machine learning approaches.通过比较机器学习方法探索 HDAC10 抑制剂的结构要求。
J Mol Graph Model. 2023 Sep;123:108510. doi: 10.1016/j.jmgm.2023.108510. Epub 2023 May 16.
7
An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies.通过诱导契合对接、药效团建模和定量构效关系研究深入了解组蛋白去乙酰化酶 8 的选择性和高效抑制作用。
J Biomol Struct Dyn. 2020 Jan;38(1):48-65. doi: 10.1080/07391102.2019.1567388. Epub 2019 Feb 7.
8
Identification of structural fingerprints among natural inhibitors of HDAC1 to accelerate nature-inspired drug discovery in cancer epigenetics.鉴定 HDAC1 的天然抑制剂中的结构指纹,以加速癌症表观遗传学中的基于自然的药物发现。
J Biomol Struct Dyn. 2024 Jul;42(11):5642-5656. doi: 10.1080/07391102.2023.2227710. Epub 2023 Jun 26.
9
Binding Free Energy (BFE) Calculations and Quantitative Structure-Activity Relationship (QSAR) Analysis of Histone Deacetylase 8 (HDAC8) Inhibitors.组蛋白去乙酰化酶 8(HDAC8)抑制剂的结合自由能(BFE)计算和定量构效关系(QSAR)分析。
Molecules. 2021 Apr 28;26(9):2584. doi: 10.3390/molecules26092584.
10
QSAR modeling to design selective histone deacetylase 8 (HDAC8) inhibitors.QSAR 建模设计选择性组蛋白去乙酰化酶 8(HDAC8)抑制剂。
Arch Pharm Res. 2016 Oct;39(10):1356-1369. doi: 10.1007/s12272-015-0705-5. Epub 2016 Aug 19.

引用本文的文献

1
Identification of structural features of surface modifiers in engineered nanostructured metal oxides regarding cell uptake through ML-based classification.基于机器学习的分类方法识别工程化纳米结构金属氧化物中表面改性剂的结构特征及其对细胞摄取的影响
Beilstein J Nanotechnol. 2024 Jul 22;15:909-924. doi: 10.3762/bjnano.15.75. eCollection 2024.

本文引用的文献

1
Neighbor List Artifacts in Molecular Dynamics Simulations.分子动力学模拟中的邻居列表伪影
J Chem Theory Comput. 2023 Dec 12;19(23):8919-8929. doi: 10.1021/acs.jctc.3c00777. Epub 2023 Nov 30.
2
CatNet: Sequence-based deep learning with cross-attention mechanism for identifying endocrine-disrupting chemicals.CatNet:基于序列的深度学习与交叉注意力机制在识别内分泌干扰化学物中的应用
J Hazard Mater. 2024 Mar 5;465:133055. doi: 10.1016/j.jhazmat.2023.133055. Epub 2023 Nov 22.
3
Development of a read-across-derived classification model for the predictions of mutagenicity data and its comparison with traditional QSAR models and expert systems.
开发一种基于类推法的分类模型以预测致突变性数据,并将其与传统定量构效关系(QSAR)模型及专家系统进行比较。
Toxicology. 2023 Dec;500:153676. doi: 10.1016/j.tox.2023.153676. Epub 2023 Nov 21.
4
A fragment-based exploration of diverse MMP-9 inhibitors through classification-dependent structural assessment.通过基于分类的结构评估对多种基质金属蛋白酶-9抑制剂进行基于片段的探索。
J Mol Graph Model. 2024 Jan;126:108671. doi: 10.1016/j.jmgm.2023.108671. Epub 2023 Nov 11.
5
Integrated Network Pharmacology and Approaches to Decipher the Pharmacological Mechanism of Thunb in Treating Gout and Its Complications.整合网络药理学及解析土牛膝治疗痛风及其并发症药理机制的方法
Comb Chem High Throughput Screen. 2025;28(1):74-88. doi: 10.2174/0113862073258523231025095117.
6
Targeted expression of a designed fusion protein containing BMP2 into the lumen of exosomes.将含有 BMP2 的设计融合蛋白靶向表达到外体的腔中。
Biochim Biophys Acta Gen Subj. 2024 Jan;1868(1):130505. doi: 10.1016/j.bbagen.2023.130505. Epub 2023 Nov 3.
7
Homology modeling, virtual screening, molecular docking, and ADME approaches to identify a potent agent targeting NK2R protein.同源建模、虚拟筛选、分子对接和 ADME 方法,以鉴定一种针对 NK2R 蛋白的有效药物。
Biotechnol Appl Biochem. 2024 Feb;71(1):213-222. doi: 10.1002/bab.2533. Epub 2023 Oct 30.
8
ScaffoldGVAE: scaffold generation and hopping of drug molecules via a variational autoencoder based on multi-view graph neural networks.支架生成变分自编码器(ScaffoldGVAE):基于多视图图神经网络的变分自编码器实现药物分子的支架生成与跳跃
J Cheminform. 2023 Oct 4;15(1):91. doi: 10.1186/s13321-023-00766-0.
9
Discovery of isatin-β-methyldithiocarbazate derivatives as New Delhi metallo- β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates.发现色酮-β-亚甲基二硫代氨基甲酸盐衍生物作为新德里金属β-内酰胺酶-1(NDM-1)抑制剂,用于治疗产 NDM-1 的临床分离株。
Biomed Pharmacother. 2023 Oct;166:115439. doi: 10.1016/j.biopha.2023.115439. Epub 2023 Sep 8.
10
Collaborative SAR Modeling and Prospective In Vitro Validation of Oxidative Stress Activation in Human HepG2 Cells.合作式 SAR 建模与人类 HepG2 细胞中氧化应激激活的前瞻性体外验证。
J Chem Inf Model. 2023 Sep 11;63(17):5433-5445. doi: 10.1021/acs.jcim.3c00220. Epub 2023 Aug 24.